Since taking office in January, President Joe Biden has sought to undo several policies that were established during Donald Trump’s administration. This week, the Biden administration announced another reversal of a Trump-era policy that limited healthcare protections for transgender people.
Health and Human Services Secretary Xavier Becerra announced that the Biden administration is undoing a Trump-era policy against transgender people in healthcare. The rollback was finalized by the Trump administration in June 2020. The protection for transgender people was also regulated by Obamacare, which Trump and the Republicans sought to repeal.
“The Supreme Court has made clear that people have a right not to be discriminated against on the basis of sex and receive equal treatment under the law, no matter their gender identity or sexual orientation. That’s why today HHS announced it will act on related reports of discrimination,” Becerra said in a statement.
“Fear of discrimination can lead individuals to forego care, which can have serious negative health consequences. It is the position of the Department of Health and Human Services that everyone - including LGBTQ people - should be able to access health care, free from discrimination or interference, period,” added Becerra.
Becerra also noted the provision in the Affordable Care Act regarding the protections in an interview with CNN Monday. During Trump’s presidency, HHS announced that it would only recognize discrimination according to the “plain meaning of the world ‘sex’ as male or female and as determined by biology.” The Supreme Court would later rule that the existing federal law prohibits job discrimination based on gender identity or sexual orientation.
Previously, Reuters reported that Biden threw his support towards a proposal made by India and South Africa on temporarily waiving IP patents on COVID-19 vaccines to make them more accessible, especially towards developing countries. Biden confirmed his support for the waiver in his comments to the press.
US Trade Representative Katherine Tai also issued a statement furthering the US’ support for temporarily waiving the IP patents, especially at a time of great need. Many Democratic lawmakers have pushed for a temporary waiver, as did many other countries, despite criticism from the pharmaceutical companies.


Japan Election 2026: Sanae Takaichi Poised for Landslide Win Despite Record Snowfall
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
U.S. to Begin Paying UN Dues as Financial Crisis Spurs Push for Reforms
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 



